Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy

by Ilse A. E. Bollen, Marijke van der Meulen, Kyra de Goede, Diederik W. D. Kuster, Michiel Dalinghaus, Jolanda van der Velden, Jolanda van der Velden
Published 2017-12-01

Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials

by Bjoern B. Burckhardt, Agnes Maria Ciplea, Anna Laven, Anna Laven, László Ablonczy, Ingrid Klingmann, Stephanie Läer, Karl Kleine, Michiel Dalinghaus, Milan Đukić, Johannes M. P. J. Breur, Marijke van der Meulen, Vanessa Swoboda, Holger Schwender, Florian B. Lagler
Published 2020-12-01

Predicting outcome in children with dilated cardiomyopathy: the use of repeated measurements of risk factors for outcome

by Marijke van derMeulen, Susanna denBoer, Gideon J. duMarchie Sarvaas, Nico Blom, Arend D.J. tenHarkel, Hans M.P.J. Breur, Lukas A.J. Rammeloo, Ronald Tanke, Ad J.J.C. Bogers, Willem A. Helbing, Eric Boersma, Michiel Dalinghaus
Published 2021-04-01

Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety...

by Milica Bajcetic, Saskia N. de Wildt, Michiel Dalinghaus, Jörg Breitkreutz, Ingrid Klingmann, Florian B. Lagler, Anne Keatley-Clarke, Johannes MPJ. Breur, Christoph Male, Ida Jovanovic, Andras Szatmári, László Ablonczy, Bjoern B. Burckhardt, Willi Cawello, Karl Kleine, Emina Obarcanin, Lucie Spatenkova, Vanessa Swoboda, Marijke van der Meulen, Peter Wagner, Jennifer Walsh, Stephanie Läer
Published 2019-09-01